Cargando…
Toxicity of psychotropic drugs in patients with COVID-19: A systematic review
OBJECTIVE: Due to the global spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), guidance for the use of psychotropic drugs in this context is necessary. We aimed to review clinical evidence regarding the potential toxicity of psychiatric medications in the context of SARS-CoV-2...
Autores principales: | Sabe, Michel, Dorsaz, Orianne, Huguelet, Philippe, Kaiser, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890235/ https://www.ncbi.nlm.nih.gov/pubmed/33631694 http://dx.doi.org/10.1016/j.genhosppsych.2021.02.006 |
Ejemplares similares
-
Psychotropic drug repurposing for COVID-19: a systematic review
por: Isayeva, U., et al.
Publicado: (2022) -
Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity
por: Telles-Correia, Diogo, et al.
Publicado: (2017) -
Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis
por: Fico, Giovanna, et al.
Publicado: (2023) -
Effect of the COVID-19 pandemic on the psychotropic drug consumption
por: Benistand, Paul, et al.
Publicado: (2022) -
Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review
por: Sepúlveda-Lizcano, Lizeth, et al.
Publicado: (2023)